Arcus Biosciences

RCUS · NYSE

$23.75+$1.61 (+7.27%)TodayMarket closed ·
Prev close $22.14

Who owns RCUS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 62.9% of RCUS’s shares.

  • Gilead Sciences, Inc.25.0%
  • BlackRock Institutional Trust Company, N.A.10.5%
  • State Street Investment Management (US)4.8%
  • Wellington Management Company, LLP4.7%
  • Next 6 largest institutions18.0%
  • All other shareholders37.1%
Top institutional holders of RCUS
HolderShares% of shares
Gilead Sciences, Inc.31.42M24.99%
BlackRock Institutional Trust Company, N.A.13.16M10.47%
State Street Investment Management (US)6.03M4.79%
Wellington Management Company, LLP5.90M4.69%
Montanova Capital, LLC4.78M3.80%
Vanguard Portfolio Management, LLC4.48M3.56%
Vanguard Capital Management, LLC3.89M3.09%
Fidelity Management & Research Company LLC3.31M2.63%
Citadel Advisors LLC3.14M2.49%
Woodline Partners LP3.01M2.39%

Largest mutual fund holders

Top mutual fund holders of RCUS
HolderShares% of shares
iShares Core S&P Small-Cap ETF5.29M4.20%
Vanguard Health Care Fund3.45M2.74%
Vanguard Total Stock Market Index Fund2.81M2.24%
State Street SPDR S&P Biotech ETF2.72M2.17%
iShares Russell 2000 ETF2.30M1.83%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $3.26M (10 trades) of RCUS on the open market, with no buys.

Latest RCUS insider transactions
InsiderTypeSharesValue
Azoy AlexanderOption exercise2.83K—
Azoy AlexanderSale2.83K$84.81K
Azoy AlexanderOption exercise2.83K$43.65K
Jaen Juan C.Sale268$7.88K
Jaen Juan C.Sale19.80K$566.41K
Jaen Juan C.Sale48.50K$1.46M
Jaen Juan C.Sale6.43K$190.74K
Jaen Juan C.Sale1.70K$47.62K
Jaen Juan C.Sale14.07K$389.48K
Jaen Juan C.Sale9.24K$249.66K

Short interest

Settled Sep 30, 2026

Shares short
13.11M
Days to cover
7.64
% of shares outstanding
10.42%
Average daily volume
1.72M
Change since last report
−5.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.